AZmed is a French company founded in 2018 with the aim of improving doctors’ working conditions and care quality. The first solution developed, Rayvolve is a computer-aided diagnosis tool able to detect all types of fractures and chest pathologies on standard X-rays. It allows radiologists and emergency physicians to save time and reduce the risk of diagnosis errors.
Rayvolve has been the first software to obtain the CE IIa MDR mark in its category, and in June 2022, it was FDA-approved for commercialization in the US (fracture product).
In 6 years, AZmed has deployed the solution in +50 countries and 5 continents (AP-HP, Hôpital Foch, University Hospital Cleveland, NHS, CHUs, Group of radiology centers). Today, more than 2000 medical imaging structures are using Rayvolve solutions throughout the world.
